摘要
根据世界脑卒中组织一世界卒中运动(worldStrokeCampaignoftheworldStrokeOrganization)的资料,1/6的人在其一生中会发生脑卒中。年龄是脑卒中最常见的危险因素,而且无论是发达国家还是发展中国家,均存在越来越明显的人口老龄化。但年轻人也可发生脑卒中,有迹象显示年龄较早的脑卒中其发生率正在增加。
出处
《卒中与神经疾病》
2013年第3期F0003-F0004,共2页
Stroke and Nervous Diseases
参考文献16
-
1Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: tempo- ral trends in stroke incidence in a large, biracial population. Neu- rology, 2012, 79(17) : 1781-1787.
-
2Stroke Unit Trialists" Collaboration. Organised inpatient (stroke unit) care for stroke. Coehrane Database Syst Rev, 2007, 4: CD000197.
-
3Jauch EC, Cucchiara B, Adeoye O, et al. Part 11 : adult stroke: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 2010, 122(Suppl 3): $818-$828.
-
4The IST-3 collaborative group. The benefits and harms of intra-venoug thromholysis with recombinant tLssue pta:mmus:a activa- tor within 6 h of acute ischaemic stroke (the third international stroke trial EIST-3]): a randomised controlled trial. Lancet, 2012, 379(9834) : 2352-2363.
-
5Rha JH, Shrivastava VP, Wang Y, et al, for the SITS Investi- gators. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW). Int J Stroke, 2012, 18. lEpub a- head of print].
-
6Wahlgren N, Ahmed N, D valos A, et al. Thrombolysis with al- teplase for acute isehaemie stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) : an observational study. Lancet, 2007, 369(9558); 275-282.
-
7Lees KR, Bluhmki E, yon Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINIkS, and EPI- THET trials. Lancet, 2010, 375(9727): 1695-1703.
-
8Leys D, Ringelstein EB, Kaste M, et al, for the Executive Com- mittee of the European Stroke Initiative. Facilities available in European hospitals treating stroke patients. Stroke, 20(17, 38 (11 ) : 2985-2991.
-
9Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol, 2012, 71(5): 634-641.
-
10Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue- type plasminogen activator therapy in acute ischemic stroke: pa- tient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation, 2011, 123(7) : 750-758.
同被引文献34
-
1马永盛,陈亮,衣兰凯.GCS和ICS及APACHEⅡ三种临床评分对昏迷患者的预后评估[J].中国全科医学,2008,11(19):1761-1762. 被引量:29
-
2付娜娜,石正洪.缺血性脑卒中病因分型研究进展[J].中国老年学杂志,2014,34(12):3489-3491. 被引量:13
-
3梅和珊,王永利.脑缺血时谷氨酸释放机制[J].中国药理学通报,2005,21(4):393-396. 被引量:38
-
4Saenger AK, Christenson RH. Stroke biomarkers: progress and chal- lenges for diagnosis, prognosis, differentiation and treatment [ J ]. Clin Chem, 2010, 56(1) : 21 -33.
-
5Laterza OF, Modur YR, Crimmins DL, et al. Identification of novel brain biomarkers[J]. Clin Chem, 2006, 52(9) : 1713 -1721.
-
6Betterman K. NMDA receptor biomarker for acute stroke [ A ]. In : Clifford B. Saper ( eds ). American Neurological Association 2011 Annual Meeting[ C]. California: John Wiley & Sons, Inc, Press, 2011 : S142.
-
7yon Kummer R, Nolte PN, Schnittger H, et al. Detectability of cere- bral hemisphere ischemic infarcts by CT within 6 h of stroke [ J ]. Neuroradiology, 1996, 38 ( 1 ) : 31 - 33.
-
8Hand PJ, Wardlaw JM, Rowat AM, et al. Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties [ J ]. J Neurol Neurosurg Psychiatry, 2005, 76 ( 11 ) : 1525 - 1527.
-
9Stejskal D, Sporova L, Svestak M, et al. Determination of serum visinin like protein - 1 and its potential for the diagnosis of brain in- jury due to the stroke: a pilot study[ J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2011, 155(3) : 263 - 268.
-
10Saenger AK, Christenson RH. Stroke biomarkers : progress and chal- lenges for diagnosis, prognosis, differentiation, and treatment [ J ]. Clin Chem, 2010, 56(1): 21 -33.
引证文献4
-
1刘玲,刘琦,李红利.急性脑梗塞动脉内溶栓治疗时间及梗塞部位等因素对疗效的影响[J].西部医学,2014,26(6):765-767. 被引量:19
-
2刘晓丽,张秀芝,蔡军,孙长义,滑世轩,姜晓峰.VILIP-1在早期缺血性脑卒中的临床诊断价值[J].中国卫生检验杂志,2014,24(15):2135-2137. 被引量:4
-
3何晓斌,潘文,刘毅,王振强.急性缺血性脑卒中介入治疗体会[J].贵州医药,2014,38(10):906-907. 被引量:4
-
4赵玉苹.缺血性脑卒中患者发病前服用抗血小板药对疾病严重程度及转归的影响[J].贵阳医学院学报,2015,40(2):192-194. 被引量:1
二级引证文献28
-
1汪东良,王锦华,韩威威,谢朝艳,方兴,谢增华,唐孝龙,陈强,吴允钦,彭勇.血清学标志物Aβ1-42、sICAM-1、VILIP-1对脑梗死后血管性痴呆的预测价值[J].中华全科医学,2019,17(2):225-229. 被引量:32
-
2常秀红.多模式CT指导下急性缺血性脑卒中的溶栓治疗[J].中国伤残医学,2015,23(2):145-146.
-
3张文,翟登月,朱幼玲,朱双根,张卫.颈动脉闭塞患者Willis环的完整性与FLAIR血管高信号征的相关性研究[J].贵州医药,2015,39(9):782-785. 被引量:1
-
4许玫.对比rt-PA与尿激酶溶栓在急性脑梗塞患者治疗中的临床效果[J].中国卫生标准管理,2015,6(22):128-129. 被引量:8
-
5郭淑娟,王琮民.雌、雄性大鼠局灶性脑缺血-再灌注早期脑损伤的研究[J].贵阳医学院学报,2016,41(2):166-169. 被引量:2
-
6李明浩.氯吡格雷联合瑞替普酶对急性脑梗死止凝血功能影响[J].河南医学高等专科学校学报,2016,28(2):101-102. 被引量:4
-
7陈廷静,蔡莉,卢蓉,李雪.脑卒中患者一体化影像检查与介入救治绿色通道的建立[J].检验医学与临床,2016,13(17):2542-2543. 被引量:13
-
8滕海英,曹丽霞,赵丽娟.TNF-α hs-CRP LDL-c与老年急性脑梗死的相关性研究[J].中国实用神经疾病杂志,2016,19(24):61-63. 被引量:8
-
9周建台,苏怀昆.急性脑梗死脑动脉内溶栓与静脉内溶栓疗效分析[J].华夏医学,2016,29(5):48-50. 被引量:3
-
10毛宏杰.大剂量尿激酶溶栓治疗急性脑梗死患者的临床观察[J].中国民康医学,2017,29(5):26-27. 被引量:5
-
1王拥军.卒中:回眸2008[J].中国卒中杂志,2009,4(1):1-9. 被引量:2
-
2王拥军.卒中——回眸2004[J].内科急危重症杂志,2005,11(5):199-202. 被引量:1
-
3薛晓英.上海市精神卫生中心设计回眸[J].中国医院建筑与装备,2011,12(3):30-32.
-
4本刊编辑部.王拥军教授在“回眸卒中2010”会议上答疑荟萃[J].中国卒中杂志,2011,6(3):223-226.
-
5王拥军.卒中:回眸2014[J].中国卒中杂志,2015,10(1):1-13. 被引量:2
-
6卢祖能.2008神经病学回眸[J].卒中与神经疾病,2009,16(5):259-261.
-
7王拥军.卒中:回眸2011[J].中国卒中杂志,2012,7(1):1-11.
-
8王拥军.卒中:回眸2009[J].中国卒中杂志,2010,5(1):1-8. 被引量:5
-
9王拥军.卒中:回眸2007[J].中国卒中杂志,2008,3(2):77-84.
-
10王拥军.卒中:回眸2016[J].中国卒中杂志,2017,12(1):1-11. 被引量:8